Marc L. Lesnick
Founder at Park Therapeutics, Inc.
Profile
Marc L.
Lesnick is the founder of Park Therapeutics, Inc. Prior to this, he worked as Senior Vice President-Regulatory Affairs & Quality at Cascadian Therapeutics LLC, Senior Vice President-Regulatory Affairs at Shionogi, Inc., and Vice President-Regulatory Affairs & Quality at Spruce Biosciences, Inc. He holds a doctorate degree from the University of Oregon.
Marc L. Lesnick active positions
Companies | Position | Start |
---|---|---|
Park Therapeutics, Inc.
Park Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Tris Pharma, Inc., Park Therapeutics, Inc. develops drugs for the treatment of pain. The company is based in Morristown, NJ. The company was founded by Marc L. Lesnick, James Hackworth. James Hackworth has been the CEO since incorporation. Park Therapeutics was acquired by Tris Pharma, Inc. on April 29, 2021. | Founder | - |
Former positions of Marc L. Lesnick
Companies | Position | End |
---|---|---|
SPRUCE BIOSCIENCES, INC. | General Counsel | - |
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Part of Shionogi & Co., Ltd., Shionogi, Inc. is a pharmaceutical company based in Florham Park, NJ. Since 1878, the company has been utilizing science to address health challenges and has discovered several novel antibiotics and medications for HIV and influenza. Shionogi conducts ongoing research into established products and new antibiotic compounds, as well as developing an investigational antiviral for COVID-19. The company is committed to pursuing discovery through partnerships, including collaboration with scientists through investigator-initiated research. Shionogi is dedicated to advancing the greater good by developing, partnering, and commercializing medicine to treat serious unmet medical needs in infectious disease and other areas of high medical need including neurology and cardiovascular disease. Nathan McCutcheon has been the CEO of the company since 2019. | General Counsel | - |
CASCADIAN THERAPEUTICS INC (USA) | General Counsel | - |
Training of Marc L. Lesnick
University of Oregon | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SPRUCE BIOSCIENCES, INC. | Health Technology |
Private companies | 3 |
---|---|
Cascadian Therapeutics LLC
Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Cascadian Therapeutics LLC is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutic products for the treatment of cancer. Its product ONT-380, is an orally active and selective small-molecule HER2 inhibitor. The firm also develops preclinical product candidates in oncology using Chk1 kinase inhibitor and protocell technology. The company was founded on September 7, 2007 and is headquartered in Bothell, WA. | Health Technology |
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Part of Shionogi & Co., Ltd., Shionogi, Inc. is a pharmaceutical company based in Florham Park, NJ. Since 1878, the company has been utilizing science to address health challenges and has discovered several novel antibiotics and medications for HIV and influenza. Shionogi conducts ongoing research into established products and new antibiotic compounds, as well as developing an investigational antiviral for COVID-19. The company is committed to pursuing discovery through partnerships, including collaboration with scientists through investigator-initiated research. Shionogi is dedicated to advancing the greater good by developing, partnering, and commercializing medicine to treat serious unmet medical needs in infectious disease and other areas of high medical need including neurology and cardiovascular disease. Nathan McCutcheon has been the CEO of the company since 2019. | Health Technology |
Park Therapeutics, Inc.
Park Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Tris Pharma, Inc., Park Therapeutics, Inc. develops drugs for the treatment of pain. The company is based in Morristown, NJ. The company was founded by Marc L. Lesnick, James Hackworth. James Hackworth has been the CEO since incorporation. Park Therapeutics was acquired by Tris Pharma, Inc. on April 29, 2021. | Health Technology |
- Stock Market
- Insiders
- Marc L. Lesnick